Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PEGON study of peginterferon alfa-2b add-on after nucleos(t)ide analogue pretreatment in HBeAg-positive chronic hepatitis B
NL-OMON37588Active, not recruiting
- Sponsor
- Stichting Leveronderzoek
- Start
- Jun 2012
- Modality
- Cytokines & Interferons → Recombinant Proteins and Enzymes, Biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
Open-label, single-arm trial of peginterferon alfa-2b in Chronic Hepatitis B (CHB), sponsored by Stichting Leveronderzoek. Primary endpoint: Sustained response. Started Jun 2012; status: active, not recruiting.
02
Drugs
peginterferon alfa-2b
03
Conditions
Chronic Hepatitis B (CHB)
Beyond the preview
Go deeper on NL-OMON37588.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON37588.